Patent ID: 11970483
Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 5:
6. The compound according to claim 1, wherein
ring A is, , wherein R5A is, (a) a mono- or di-C1-6 alkyl-carbamoyl group optionally substituted by 1 or 2 substituents selected from
(i) a C1-6 alkoxy group,
(ii) a 3- to 14-membered non-aromatic heterocyclic group, and
(iii) a mono- or di-C1-6 alkyl-carbamoyl group, or, (b) a carbamoyl group optionally substituted by 1 or 2 substituents selected from
(i) a C3-10 cycloalkyl group, and
(ii) a 3- to 14-membered non-aromatic heterocyclic group optionally substituted by 1 to 3 C1-6 alkyl groups;, Y is CR6A or N; and, R6A is a hydrogen atom or a halogen atom,, or a salt thereof.